<DOC>
	<DOCNO>NCT00284518</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness different dos botulinum toxin Type A treat low urinary tract symptom due benign prostatic hyperplasia .</brief_summary>
	<brief_title>Safety Efficacy Study Botulinum Toxin Type A Treat Lower Urinary Symptoms Due Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Lower urinary tract symptom due benign prostatic hyperplasia Enlarged prostate volume rectal ultrasound Previous prostate surgery Previous current diagnosis prostate cancer Use medication treatment prostatic hyperplasia Urinary tract infection</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>